Streetbeat News

Partnerships

JNVR

Janover Inc (NASDAQ:JNVR) has launched Janover Insurance Group, a new insurtech subsidiary. The venture will integrate with Janover's AI applications and marketing funnel, which has over 88 million annual impressions on Google. This integration is expected to provide broad distribution and operational efficiencies. Janover Insurance Group will initially focus on multifamily and commercial property insurance, with plans to expand to SMB clients. The company aims to transform commercial property insurance using generative AI and data access. Tyler Schapiro, CEO of Flagler Insurance, has been tapped as a strategic advisor to enhance the subsidiary's expertise.

Portfolio Pulse from Anusuya Lahiri

January 08, 2024 | 1:45 pm

HSAI

Hesai Technology (NASDAQ:HSAI) announced two new ADAS lidar products, the AT512 and ET25, and the completion of its 'Maxwell' R&D and manufacturing center. The AT512 offers a 300m range at 10% reflectivity, with a record 12.3 million points per second, while the ET25 is an ultra-thin lidar with a 250m range. The 'Maxwell' center features advanced lidar testing and smart industrial robots for automated production. Hesai has also won a lidar design contract with a global OEM and has delivered 300,000 units to date, with 50,000 in December alone.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:39 pm

INVZ

Innoviz Technologies Ltd. (INVZ) will participate in CES 2024, showcasing the BMW i7 and Volkswagen ID. Buzz, both integrated with Innoviz's LiDAR technology. The BMW i7, featuring InnovizOne LiDAR, is available for order in Germany, with deliveries starting March 2024. The VW ID. Buzz, equipped with InnovizTwo LiDAR, highlights level 4 autonomous capabilities. Innoviz will also demonstrate Innoviz360 and has been named a CES 2024 Innovation Awards Honoree for its InnovizCore Compute Module.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:37 pm

EDIT

Editas Medicine, Inc. (NASDAQ: EDIT) announced its 2024 strategic priorities and anticipated milestones at the J.P. Morgan Healthcare Conference. The company plans to present reni-cel clinical data updates, initiate the RUBY trial adolescent cohort, establish in vivo preclinical proof-of-concept for an undisclosed indication, and continue sublicensing its foundational IP. Editas has a strong financial position with a runway into 2026. The company's focus remains on developing reni-cel towards BLA and commercialization, building an in vivo pipeline, and increasing business development activities. Revenue is expected from licensing agreements with Vertex Pharmaceuticals and Vor Bio.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:35 pm

BA

SPR

Spirit Aerosystems has publicly affirmed its commitment as a partner with Boeing on the 737 program, emphasizing ongoing collaboration to address issues related to the program.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:31 pm

ENSC

Ensysce Biosciences CEO Lynn Kirkpatrick released a 2024 shareholder letter detailing the company's progress in 2023, focusing on the development of their lead analgesic PF614 and PF614-MPAR, both designed to treat severe pain with overdose protection. The company presented clinical data at various scientific meetings, completed clinical trials, and prepared for regulatory submissions to the FDA. They also engaged Alacrita Consulting for business development and explored a partnership with OncoZenge AB for a non-opioid pain treatment. Ensysce raised $12 million in financing to support their clinical programs and is preparing for FDA discussions to advance PF614 and PF614-MPAR through the 505(B)(2) regulatory pathway.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:23 pm

BT

BT Group's tech incubation unit, Etc., plans to convert traditional broadband street cabinets into EV charging stations in the U.K. The first conversion will take place in East Lothian, Scotland, with technical trials across 60,000 cabinets to address the shortage of public EV charging points. The U.K. government aims to increase charging points to 300,000 by 2030, and BT Group's initiative could help overcome the infrastructure barrier deterring potential EV buyers. The project will assess technical, commercial, and operational factors and has been recognized with an Innovation Honoree award at CES for 2024.

Portfolio Pulse from Benzinga Neuro

January 08, 2024 | 1:22 pm

NXST

Nexstar Media has entered into a time brokerage agreement with KAZT-TV, which will become an affiliate of The CW Network starting February 1. The multi-year agreement allows Nexstar, the nation's leading local TV broadcaster, to partner in the 11th largest television market. Financial terms of the deal were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:22 pm

ASND

Vector Pharma FZCO has entered into an exclusive distribution agreement with Ascendis Pharma for the commercialization of Skytrofa and Yorvipath in the Middle East, covering Saudi Arabia, United Arab Emirates, Kuwait, Oman, Qatar, and Bahrain.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:21 pm